HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

BIM 23034

inhibits the clonal growth & vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells; amino acid sequence given in first source
Also Known As:
BIM-23034; Phe-Cys-Tyr-Trp-Lys-Val-Cys-3-(2-naphthyl)-Ala-NH2; D-Alaninamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-3-(2-naphthalenyl)-, cyclic (2-7)-disulfide
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Small Cell Lung Carcinoma (Small Cell Lung Cancer)

Related Drugs and Biologics

1. Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
2. Somatostatin (Somatotropin Release-Inhibiting Factor)
3. Cyclic AMP (AMP, Cyclic)
4. angiopeptin